Dopamine agonist action of phencyclidine.
Philip Seeman, Mercedes Lasaga
Synapse December 15, 2005 DOI: 10.1002/syn.20210 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | In vitro experimental study Peer reviewed |
|---|---|
| Population | Rat cultured anterior pituitary cells |
| Intervention | Phencyclidine |
| Dose | 4 nM |
| Measures | prolactin release |
| Key findings | Phencyclidine acts as a potent dopamine-like agonist at the functional high-affinity state of the dopamine D2 receptor, inhibiting prolactin release by 50% at 4 nM. |
Abstract
Although the psychotomimetic action of phencyclidine is often used to model a hypoglutamate theory of psychosis or schizophrenia, work also exists showing that phencyclidine has a significant affinity for the dopamine D2 receptor. The present study was done to determine whether phencyclidine has a direct functional dopamine-like action on cells. The effect of phencyclidine was tested on the release of prolactin from rat cultured anterior pituitary cells. It was found that the release of prolactin was 50% inhibited by 4 nM phencyclidine. This strong dopamine-like agonist action at the functional high-affinity state of the dopamine D2 receptor by the phencyclidine psychotomimetic is consistent with the dopamine hypothesis of psychosis.
Citations in the library
Cited by 8
- Dopamine D2High receptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil. Synapse August 1, 2009
- Effect fingerprinting of new psychoactive substances (NPS): What can we learn from in vitro data? Pharmacology & Therapeutics February 1, 2018
- Hippocampal serotonin depletion unmasks differences in the hyperlocomotor effects of phencyclidine and MK-801: quantitative versus qualitative analyses Frontiers in Pharmacology 2013
- The psychotomimetic ketamine disrupts the transfer of late sensory information in the corticothalamic network bioRxiv Preprint Server February 21, 2022
- In Vitro and In Vivo Pharmaco-Toxicological Characterization of 1-Cyclohexyl-x-methoxybenzene Derivatives in Mice: Comparison with Tramadol and PCP. International Journal of Molecular Sciences July 17, 2021
and 3 more in the library
Cites 4
- Recent advances in the phencyclidine model of schizophrenia American Journal of Psychiatry October 1, 1991
- The role of striatal dopaminergic mechanisms in rotational behavior induced by phencyclidine and phencyclidine-like drugs. Psychopharmacology 1998
- Glutamate pharmacology and the treatment of schizophrenia: current status and future directions. International Clinical Psychopharmacology September 1, 1995
- Comparison of Haloperidol and Chlorpromazine in the Treatment of Phencyclidine Psychosis The Journal of Clinical Pharmacology April 1, 1984